Lista de obras - Marta Valenza - Dominio Público Uruguay

A gene network regulating lysosomal biogenesis and function

artículo científico publicado en 2009

An evolutionary recent neuroepithelial cell adhesion function of huntingtin implicates ADAM10-Ncadherin

artículo científico publicado en 2012

Analysis of the repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy of non-neuronal genes in peripheral lymphocytes from patients with Huntington's disease

artículo científico publicado en 2008

Brain-derived neurotrophic factor in patients with Huntington's disease

artículo científico publicado en 2011

Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation.

artículo científico publicado en 2007

Cholesterol defect is marked across multiple rodent models of Huntington's disease and is manifest in astrocytes

artículo científico publicado en 2010

Cholesterol dysfunction in neurodegenerative diseases: is Huntington's disease in the list?

artículo científico publicado en 2006

Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice

artículo científico publicado en 2015

Disruption of astrocyte-neuron cholesterol cross talk affects neuronal function in Huntington's disease.

artículo científico publicado en 2014

Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease.

artículo científico publicado en 2005

Early and brain region-specific decrease of de novo cholesterol biosynthesis in Huntington's disease: A cross-validation study in Q175 knock-in mice

artículo científico publicado en 2016

Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses

artículo científico publicado en 2002

Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses

artículo científico publicado en 2014

Emerging roles for cholesterol in Huntington's disease ⬇️

artículo científico publicado el 19 de julio de 2011

Evaluation of histone deacetylases as drug targets in Huntington's disease models. Study of HDACs in brain tissues from R6/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model

artículo científico publicado en 2010

Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes

artículo científico publicado en 2003

In vitro and in vivo models of Huntington's disease show alterations in the endocannabinoid system

scientific journal article

Lack of huntingtin promotes neural stem cells differentiation into glial cells while neurons expressing huntingtin with expanded polyglutamine tracts undergo cell death

artículo científico publicado en 2012

Loss of huntingtin function complemented by small molecules acting as repressor element 1/neuron restrictive silencer element silencer modulators

artículo científico publicado en 2007

Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease ⬇️

artículo científico publicado el 1 de julio de 2010

Neuroprotection and brain cholesterol biosynthesis in Huntington's disease

artículo científico publicado en 2010

Peroxisome-proliferator-activated receptor gamma coactivator 1 α contributes to dysmyelination in experimental models of Huntington's disease

artículo científico publicado en 2011

Pitfalls in the detection of cholesterol in Huntington's disease models

artículo científico publicado en 2012

Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease.

artículo científico publicado en 2008

Prevention of cytosolic IAPs degradation: a potential pharmacological target in Huntington's Disease

artículo científico publicado en 2005

Progressive dysfunction of the cholesterol biosynthesis pathway in the R6/2 mouse model of Huntington's disease.

artículo científico publicado en 2007

Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery

artículo científico publicado en 2005

Striatal infusion of cholesterol promotes dose-dependent behavioral benefits and exerts disease-modifying effects in Huntington's disease mice

scientific article published on 22 September 2020

Whole body cholesterol metabolism is impaired in Huntington's disease.

artículo científico publicado en 2011

Lista de obras de Marta Valenza

A gene network regulating lysosomal biogenesis and function

An evolutionary recent neuroepithelial cell adhesion function of huntingtin implicates ADAM10-Ncadherin

Analysis of the repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy of non-neuronal genes in peripheral lymphocytes from patients with Huntington's disease

Brain-derived neurotrophic factor in patients with Huntington's disease

Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation.

Cholesterol defect is marked across multiple rodent models of Huntington's disease and is manifest in astrocytes

Cholesterol dysfunction in neurodegenerative diseases: is Huntington's disease in the list?

Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice

Disruption of astrocyte-neuron cholesterol cross talk affects neuronal function in Huntington's disease.

Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease.

Early and brain region-specific decrease of de novo cholesterol biosynthesis in Huntington's disease: A cross-validation study in Q175 knock-in mice

Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses

Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses

Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses

Emerging roles for cholesterol in Huntington's disease ⬇️

Evaluation of histone deacetylases as drug targets in Huntington's disease models. Study of HDACs in brain tissues from R6/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model

Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes

In vitro and in vivo models of Huntington's disease show alterations in the endocannabinoid system

Lack of huntingtin promotes neural stem cells differentiation into glial cells while neurons expressing huntingtin with expanded polyglutamine tracts undergo cell death

Loss of huntingtin function complemented by small molecules acting as repressor element 1/neuron restrictive silencer element silencer modulators

Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease ⬇️

Neuroprotection and brain cholesterol biosynthesis in Huntington's disease

Peroxisome-proliferator-activated receptor gamma coactivator 1 α contributes to dysmyelination in experimental models of Huntington's disease

Pitfalls in the detection of cholesterol in Huntington's disease models

Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease.

Prevention of cytosolic IAPs degradation: a potential pharmacological target in Huntington's Disease

Progressive dysfunction of the cholesterol biosynthesis pathway in the R6/2 mouse model of Huntington's disease.

Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery

Striatal infusion of cholesterol promotes dose-dependent behavioral benefits and exerts disease-modifying effects in Huntington's disease mice

Whole body cholesterol metabolism is impaired in Huntington's disease.